Introduction Reliable rapid testing on COVID-19 is needed in care homes to reduce the risk of outbreaks and enable timely care. Point-of-care testing (POCT) in care homes could provide rapid actionable results. This study aimed to examine the usability and test performance of point of care polymerase chain reaction (PCR) for COVID-19 in care homes. Methods Point-of-care PCR for detection of SARS-COV2 was evaluated in a purposeful sample of four UK care homes. Test agreement with laboratory real-time PCR and usability and use errors were assessed. Results Point of care and laboratory polymerase chain reaction (PCR) tests were performed on 278 participants. The point of care and laboratory tests returned uncertain results or errors for 17 and 5 specimens respectively. Agreement analysis was conducted on 256 specimens. 175 were from staff: 162 asymptomatic; 13 symptomatic. 69 were from residents: 59 asymptomatic; 10 symptomatic. Asymptomatic specimens showed 83.3% (95% CI: 35.9%-99.6%) positive agreement and 98.7% negative agreement (95% CI: 96.2%-99.7%), with overall prevalence and bias-adjusted kappa (PABAK) of 0.965 (95% CI: 0.932-0.999). Symptomatic specimens showed 100% (95% CI: 2.5%-100%) positive agreement and 100% negative agreement (95% CI: 85.8%-100%), with overall PABAK of 1. No usability-related hazards emerged from this exploratory study. Conclusion Applications of point-of-care PCR testing in care homes can be considered with appropriate preparatory steps and safeguards. Agreement between POCT and laboratory PCR was good. Further diagnostic accuracy evaluations and in-service evaluation studies should be conducted, if the test is to be implemented more widely, to build greater certainty on this initial exploratory analysis.
[1]
P. Buckle,et al.
COVID-19 testing in English care homes and implications for staff and residents
,
2021,
Age and ageing.
[2]
A. Pollock,et al.
Asymptomatic transmission of covid-19
,
2020,
BMJ.
[3]
P. Buckle,et al.
Understanding COVID-19 testing pathways in English care homes to identify the role of point-of-care testing: an interview-based process mapping study
,
2020,
medRxiv.
[4]
B. Hanratty,et al.
SEeking AnsweRs for Care Homes during the COVID-19 pandemic (COVID SEARCH)
,
2020,
Age and ageing.
[5]
Mohsen Golabi,et al.
Point-of-care devices for pathogen detections: The three most important factors to realise towards commercialization
,
2020
.
[6]
C. Goodman,et al.
THE COVID-19 PANDEMIC IN UK CARE HOMES – REVEALING THE CRACKS IN THE SYSTEM
,
2020,
The Journal of Nursing Home Research Sciences.
[7]
Preliminary report from the Joint PHE Porton Down & University of Oxford SARS-CoV-2 test development and validation cell: Rapid evaluation of Lateral Flow Viral Antigen detection devices
,
2020
.
[8]
Rick Lukanz,et al.
Health and Social Care
,
2018,
Public Service Accountability.
[9]
Whole Grain Label Statements.
Guidance for Industry and FDA Staff
,
2006
.
[10]
T. Welty,et al.
Point-of-Care Testing: An Introduction
,
2004,
The Annals of pharmacotherapy.